For: | Shiozawa K, Watanabe M, Kikuchi Y, Kudo T, Maruyama K, Sumino Y. Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study. World J Gastroenterol 2012; 18(40): 5753-5758 [PMID: 23155317 DOI: 10.3748/wjg.v18.i40.5753] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i40/5753.htm |
Number | Citing Articles |
1 |
Maria Assunta Zocco, Matteo Garcovich, Andrea Lupascu, Enrico Di Stasio, Davide Roccarina, Brigida Elenora Annicchiarico, Laura Riccardi, Maria Elena Ainora, Francesca Ponziani, Gianluigi Caracciolo, Gian Lodovico Rapaccini, Raffaele Landolfi, Massimo Siciliano, Maurizio Pompili, Antonio Gasbarrini. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: The role of dynamic contrast enhanced ultrasound. Journal of Hepatology 2013; 59(5): 1014 doi: 10.1016/j.jhep.2013.06.011
|
2 |
Jae Young Lee, Yasunori Minami, Byung Ihn Choi, Won Jae Lee, Yi-Hong Chou, Woo Kyoung Jeong, Mi-Suk Park, Nobuki Kudo, Min Woo Lee, Ken Kamata, Hiroko Iijima, So Yeon Kim, Kazushi Numata, Katsutoshi Sugimoto, Hitoshi Maruyama, Yasukiyo Sumino, Chikara Ogawa, Masayuki Kitano, Ijin Joo, Junichi Arita, Ja-Der Liang, Hsi-Ming Lin, Christian Nolsoe, Odd Helge Gilja, Masatoshi Kudo. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Ultrasonography 2020; 39(3): 191 doi: 10.14366/usg.20057
|
3 |
Ivan Göcze, Philipp Renner, Bernhard M. Graf, Hans J. Schlitt, Thomas Bein, Karin Pfister. Simplified approach for the assessment of kidney perfusion and acute kidney injury at the bedside using contrast-enhanced ultrasound. Intensive Care Medicine 2015; 41(2): 362 doi: 10.1007/s00134-014-3554-7
|
4 |
Hitoshi Maruyama, Tadashi Sekimoto, Osamu Yokosuka. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience. Journal of Gastroenterology 2016; 51(5): 421 doi: 10.1007/s00535-015-1151-3
|
5 |
NORITAKA WAKUI, MITSURU FUJITA, YOSHIYA YAMAUCHI, YUKI TAKEDA, NOBUO UEKI, TAKAFUMI OTSUKA, NOBUYUKI OBA, SHUTA NISHINAKAGAWA, TOSHIKO TAKEZOE, JUNKO HIROYOSHI, YOSHIHARU KONO, SEIICHIRO KATAHIRA, MASAMI MINAGAWA, YASUSHI TAKEDA, SAORI SHIONO, TATSUYA KOJIMA. Mucinous cystadenocarcinoma of the appendix in which contrast-enhanced ultrasonography was useful for assessing blood flow in a focal nodular lesion in the tumor cavity: A case report. Experimental and Therapeutic Medicine 2013; 6(1): 3 doi: 10.3892/etm.2013.1094
|
6 |
KAZUE SHIOZAWA, MANABU WATANABE, TAKASHI IKEHARA, YASUSHI MATSUKIYO, MICHIO KOGAME, MASAHIRO KANAYAMA, TEPPEI MATSUI, YOSHINORI KIKUCHI, KOJI ISHII, YOSHINORI IGARASHI, YASUKIYO SUMINO. Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report. Oncology Letters 2014; 7(1): 50 doi: 10.3892/ol.2013.1664
|
7 |
Richard G. Barr, Pintong Huang, Yan Luo, Xiaoyan Xie, Rongqin Zheng, Kun Yan, Xiang Jing, Yukun Luo, Huixiong Xu, Xiang Fei, Jeong Min Lee. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid. Abdominal Radiology 2020; 45(11): 3779 doi: 10.1007/s00261-020-02573-9
|
8 |
Hisashi Hidaka, Takahide Nakazawa, Shigeru Fujii, Michiko Yanagihara, Tsutomu Minamino, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Akitaka Shibuya, Wasaburo Koizumi. Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography. Hepatology Research 2015; 45(9): 976 doi: 10.1111/hepr.12440
|
9 |
S. Colagrande, L. Calistri, C. Campani, G. Dragoni, C. Lorini, C. Nardi, A. Castellani, F. Marra. CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib. European Radiology 2021; 31(3): 1608 doi: 10.1007/s00330-020-07171-3
|
10 |
Wen-Tao Kong, Hai-Xia Yuan, Hao Cai, Wen-Ping Wang, Yang Tang, Xiao-Long Zhang. Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound. Tumor Biology 2015; 36(4): 2593 doi: 10.1007/s13277-014-2877-x
|
11 |
Mohamed Bouattour, Audrey Payancé, Johanna Wassermann. Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging. World Journal of Hepatology 2015; 7(20): 2245-2263 doi: 10.4254/wjh.v7.i20.2245
|
12 |
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, Shuhei Yamamoto, Takashi Matsui, Yoshinori Saigusa, Yoshinori Igarashi, Iruru Maetani. Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. World Journal of Hepatology 2018; 10(1): 95-104 doi: 10.4254/wjh.v10.i1.95
|
13 |
Glen M. Lo, Hassan Al Zahrani, Hyun Jung. Jang, Ravi Menezes, John Hudson, Peter Burns, Mairéad G. McNamara, Sonja Kandel, Korosh Khalili, Jennifer Knox, Patrik Rogalla, Tae Kyoung Kim. Detection of Early Tumor Response to Axitinib in Advanced Hepatocellular Carcinoma by Dynamic Contrast Enhanced Ultrasound. Ultrasound in Medicine & Biology 2016; 42(6): 1303 doi: 10.1016/j.ultrasmedbio.2016.01.025
|
14 |
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, Yasushi Matsukiyo, Michio Kogame, Teppei Matsui, Masahiro Kanayama, Koji Ishii, Yoshinori Igarashi, Yasukiyo Sumino. Evaluation of unenhanced and contrast-enhanced ultrasonography for advanced hepatocellular carcinoma treated with sorafenib. Kanzo 2013; 54(9): 635 doi: 10.2957/kanzo.54.635
|
15 |
KAZUE SHIOZAWA, MANABU WATANABE, TAKASHI IKEHARA, MICHIO KOGAME, YOSHINORI KIKUCHI, YOSHINORI IGARASHI, YASUKIYO SUMINO. Therapeutic evaluation of sorafenib for hepatocellular carcinoma using contrast-enhanced ultrasonography: Preliminary result. Oncology Letters 2016; 12(1): 579 doi: 10.3892/ol.2016.4669
|
16 |
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, Ryo Shimizu, Mie Shinohara, Yoshinori Igarashi, Yasukiyo Sumino. Evaluation of sorafenib for advanced hepatocellular carcinoma with low α-fetoprotein in arrival time parametric imaging using contrast-enhanced ultrasonography. Journal of Medical Ultrasonics 2017; 44(1): 101 doi: 10.1007/s10396-016-0757-2
|
17 |
Yu Duan, Xiaoyan Xie, Qian Li, Nathaniel Mercaldo, Anthony E. Samir, Ming Kuang, Manxia Lin. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound–based multivariable model analysis. European Radiology 2020; 30(9): 4741 doi: 10.1007/s00330-020-06834-5
|
18 |
Simona Leoni, Ilaria Serio, Anna Pecorelli, Sara Marinelli, Luigi Bolondi. Contrast-Enhanced Ultrasound in Liver Cancer. Hepatic Oncology 2015; 2(1): 51 doi: 10.2217/hep.14.25
|
19 |
Lucia Cerrito, Maria Elena Ainora, Giuseppe Cuccia, Linda Galasso, Irene Mignini, Giorgio Esposto, Matteo Garcovich, Laura Riccardi, Antonio Gasbarrini, Maria Assunta Zocco. Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies. Cancers 2024; 16(3): 551 doi: 10.3390/cancers16030551
|
20 |
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, Yasushi Matsukiyo, Masahiro Kanayama, Masao Shinohara, Koji Ishii, Yasukiyo Sumino. Evaluation of sorafenib for hepatocellular carcinoma by arrival time parametric imaging using contrast-enhanced ultrasonography with Sonazoid. Kanzo 2013; 54(5): 363 doi: 10.2957/kanzo.54.363
|
21 |
NORITAKA WAKUI, RYUJI TAKAYAMA, NAOHISA KAMIYAMA, KOJIRO KOBAYASHI, DAIGO MATSUI, YASUSHI MATSUKIYO, TAKENORI KANEKAWA, TAKASHI IKEHARA, KOJI ISHII, YASUKIYO SUMINO. Arrival time parametric imaging using Sonazoid-enhanced ultrasonography is useful for the detection of spoke-wheel patterns of focal nodular hyperplasia smaller than 3 cm. Experimental and Therapeutic Medicine 2013; 5(6): 1551 doi: 10.3892/etm.2013.1048
|
22 |
Naoki Kamachi, Masahito Nakano, Shusuke Okamura, Takashi Niizeki, Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Yu Noda, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura. Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound. Cancer Reports 2022; 5(2) doi: 10.1002/cnr2.1471
|
23 |
KAZUE SHIOZAWA, MANABU WATANABE, TAKASHI IKEHARA, KOJIRO KOBAYASHI, YUTA OCHI, YUTA SUZUKI, KAZUHIRO FUCHINOUE, MASATAKA YONEDA, TAKESHI KENMOCHI, YUSUKE OKUBO, TAKAYUKI MORI, HIROYUKI MAKINO, NOBUHIRO TSUKAMOTO, YOSHINORI IGARASHI, YASUKIYO SUMINO. Evaluation of contrast-enhanced ultrasonography for hepatocellular carcinoma prior to and following stereotactic body radiation therapy using the CyberKnife® system: A preliminary report. Oncology Letters 2016; 11(1): 208 doi: 10.3892/ol.2015.3874
|